Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PROSPECT(TM) GIARDIA RAPID ASSAY, MODIFICATION

K-Number: K931147 · 1993-05-13

ApplicantAlexon, Inc.
Decision Date1993-05-13
Product CodeMHI
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

PROSPECT(TM) GIARDIA RAPID ASSAY, MODIFICATION is the device name listed in this FDA 510(k) record. The listed applicant is Alexon, Inc.. It received FDA 510(k) clearance on 1993-05-13 under 510(k) number K931147. The device is classified under product code MHI. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PROSPECT(TM) GIARDIA RAPID ASSAY, MODIFICATION?

PROSPECT(TM) GIARDIA RAPID ASSAY, MODIFICATION is a medical device that received FDA 510(k) clearance on 1993-05-13. The listed applicant is Alexon, Inc.. The 510(k) number is K931147.

When did PROSPECT(TM) GIARDIA RAPID ASSAY, MODIFICATION receive FDA 510(k) clearance?

PROSPECT(TM) GIARDIA RAPID ASSAY, MODIFICATION received FDA 510(k) clearance on 1993-05-13, under 510(k) number K931147.

Who is the listed applicant for PROSPECT(TM) GIARDIA RAPID ASSAY, MODIFICATION?

The FDA 510(k) record lists Alexon, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PROSPECT(TM) GIARDIA RAPID ASSAY, MODIFICATION?

The FDA product code for PROSPECT(TM) GIARDIA RAPID ASSAY, MODIFICATION is MHI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Alexon, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K934493PROSPECT MICROPLATE ASSAYK942098PROSPECT GIARDIAK930451PROSPEC T GIARDIA MICROTITER ASSAYK922675PROSPECT GIARDIA CONTROLSK922010PROSPECT(TM) GIARDIA MICROTITER ASSAY/MODIFICATIONK920817MODIFICATION PROSPECT GIARDIA RAPID ASSAY

View all 10 devices →

Related Devices (Code: MHI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K120001UNIGOLD GIARDIATrinity BiotechK103673GIARDIA/ CRYPTOSPORIDIUM QUIK CHEKTechlab Inc., Corporate Research CenterK081064GIARDIA FECAL ANTIGEN DETECTION LATERAL FLOW KIT, MODEL GL-LFIvd Research, Inc.K031942XPECT GIARDIA LATERAL FLOW ASSAY, MODEL 2450020Remel, Inc.K031834XPECT GIARDIA/CRYPTOSPORIDIUM LATERAL FLOW ASSAYRemel, Inc.K033274GIARDIA IITechlab, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑